arrow
T

Tarja Kokkola

University of Eastern Finland
H指数:27
被引数:2,576

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The performance of plasma pTau181 and pTau217 in distinguishing Alzheimer's disease from various neurodegenerative disorders, psychiatric disorders, and cognitively unimpaired controls

血浆pTau181和pTau217在区分阿尔茨海默病与各种神经退行性疾病、精神障碍以及认知未受损对照方面的性能

2026-03-230
PRE
Combining a computerized cognitive test with serum biomarkers improves detection of early-onset neurodegenerative disorders

结合计算机化认知测试与血清生物标志物可提高对早发性神经退行性疾病的检测。

2025-10-270
OA
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study

Imi-direct研究中人血浆代谢物在糖尿病前期和2型糖尿病中的作用

2024-09-301
OAAI
The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1: An IMI DIRECT Study

心脏代谢,饮食和生活方式参数与血浆胰高血糖素样肽-1的关联: IMI直接研究

2024-04-300
OA
Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits

血液分子表型的遗传分析揭示了影响复杂性状的调控网络中的共同特性

2023-08-216
OAAI
A FinnGen pilot clinical recall study for Alzheimer's disease
2023-08-031
OAAI
Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models
2023-06-017
OAAI
Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models (vol 41, pg 399, 2023)

2型糖尿病与生成性深度学习模型的药物组学关联的发现 (第41卷,399页,2023)

2023-05-020
OAAI
Serum Cathepsin S Levels Do Not Show Alterations in Different Clinical, Neuropathological, or Genetic Subtypes of Frontotemporal Dementia Patients nor in Comparison to Healthy Control Individuals
2023-04-010
PRE
Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models

通过生成性深度学习模型发现2型糖尿病的药物组学关联

2023-01-0239
OAAI
Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype
2022-10-1112
OAAI
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study
2022-01-0154
OAAI